Ryszard Kole
Geen lopende functies
Profiel
Ryszard Kole worked as the Senior Vice President-Discovery Research at Sarepta Therapeutics, Inc. Prior to that, he was the President & Chief Scientific Officer at Ercole Biotech, Inc. He also worked as a Professor-Pharmacology Department at The University of North Carolina at Charlotte.
Kole holds a doctorate degree from the Polish Academy of Sciences.
Eerdere bekende functies van Ryszard Kole
| Bedrijven | Functie | Einde |
|---|---|---|
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | President | - |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Ryszard Kole
| Polish Academy of Sciences | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
